Valsartan Tablet, Film Coated
Product Images NDC 82804-154

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 82804-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

82804-154-90 (Valsartantab160mg 30scount)

82804-154-90 (Valsartantab160mg 30scount)
This is a pharmaceutical label for Valsartan 160mg tablets, which are film-coated and oval-shaped. Each tablet contains 160mg of Valsartan, a medication used to treat high blood pressure and heart failure. The tablets are light yellowish-brown in color and are imprinted with '184' on one side and 'H' on the other. They are packaged in a bottle containing 90 tablets. The manufacturer is listed as HETERO™ Hetero Labs Limited in India. The label includes storage instructions to keep the medication at 20°-25°C (68°-77°F) and a caution to keep the medication out of the reach of children.*
FDA Label Image

Valsartantabfig1 (Valsartantabfig1)

Valsartantabfig1 (Valsartantabfig1)
This text presents data on subgroups in a study comparing Valsartan and Captopril, including age groups (<65y, >65y), gender (Male, Female), ethnicity (Caucasian, Non-Caucasian), location (US, Non-US), and beta-blocker medication status. The table shows the percentage of patients in each subgroup and indicates which treatment (Valsartan or Captopril) was favored in the study.*
FDA Label Image

Valsartantabstructure (Valsartantabstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.